Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Medicines with the Active Ingredient Ivermectin (Atc: P02cf01)

Conclusion of Agreements for the Economical Supply of Contrast Media with Various Active Ingredients or Combinations of Active Ingredients as Part of an Open House Model

Medicines with the Active Ingredient Teriparatide (Atc: H05aa02)

Medicines with the Active Ingredient Fluorouracil (Atc: D11af05)

Medicines with the Active Ingredient Ebastine (Atc: R06ax22)

Medicines with the Active Ingredient Bempedoic Acid (Atc: C10ax15)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Rotigotine (N04bc09) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Fondaparinux (B01ax05) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Sarilumab (L04ac14) as Part of a So-Called Open House Model.